Interferon-alpha, unlike interferon-gamma, does not cause bone loss in the rat.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Bone

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10511113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A new rapid and reproducible homologous immunoradiometric assay for amino-terminal parathyroid hormone in the rat

  2004cited by this paper
• Alendronate prevents cyclosporin A-induced osteopenia in the rat.

  1997cited by this paper
• Estimates of the Cost-Effectiveness of a Single Course of Interferon-2b in Patients with Histologically Mild Chronic Hepatitis C

  1997cited by this paper
• Long-Term Histologic Improvement and Loss of Detectable Intrahepatic HCV RNA in Patients with Chronic Hepatitis C and Sustained Response to Interferon- Therapy

  1997cited by this paper
• The Role of Testosterone in Cyclosporine‐Induced Osteopenia

  1997cited by this paper
• T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia.

  1996cited by this paper
• Long-term treatment of osteopetrosis with recombinant human interferon gamma.

  1995cited by this paper
• The role of adjuvant therapy in melanoma management

  1995cited by this paper
• A brief history of the use of interferons as treatment of multiple sclerosis.

  1994cited by this paper
• Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.

  1994cited by this paper
• The deleterious effects of long-term cyclosporine A, cyclosporine G, and FK506 on bone mineral metabolism in vivo.

  1994cited by this paper
• Regulation of cytokine expression by interferon-alpha in human bone marrow stromal cells: inhibition of hematopoietic growth factors and induction of interleukin-1 receptor antagonist.

  1994cited by this paper
• Primary melanoma of urinary bladder.

  1992cited by this paper
• AIDS-associated Kaposi's sarcoma and the mechanisms of interferon alpha's activity; a riddle within a puzzle.

  1992cited by this paper
• The interferons. Mechanisms of action and clinical applications.

  1991cited by this paper
• Salmon calcitonin prevents cyclosporin-A-induced high turnover bone loss.

  1991cited by this paper
• Interferons and bone. A comparison of the effects of interferon-alpha and interferon-gamma in cultures of human bone-derived cells and an osteosarcoma cell line.

  1990cited by this paper
• The effects of gamma-interferon on human peripheral blood monocyte/macrophage-mediated bone particle degradation.

  1990cited by this paper
• 1,25 dihydroxyvitamin D3 modifies cyclosporine-induced bone loss

  1990cited by this paper
• Interleukin‐1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro

  1989cited by this paper
• Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee.

  1987cited by this paper
• Inhibition of parathormone-stimulated bone resorption by type I interferon.

  1984cited by this paper
• Specific molecular activities of recombinant and hybrid leukocyte interferons.

  1982cited by this paper
• New biochemical marker for bone metabolism. Measurement by radioimmunoassay of bone GLA protein in the plasma of normal subjects and patients with bone disease.

  1980cited by this paper

• Differential Gene Expression Profiles and Pathways Highlight the Role of Osteoimmunology in Neurofibromatosis Type 1–Related Dystrophic Scoliosis With Osteopenia

  2023cites this paper
• IFN-g stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation

  2018cites this paper
• Pegylated interferon α/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection

  2017cites this paper
• Cells of the Immune System Orchestrate Changes in Bone Cell Function

  2013cites this paper
• Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts

  2013cites this paper
• Methylation pattern of IFNG in periapical granulomas and radicular cysts.

  2013cites this paper
• IFN-γ directly inhibits TNF-α-induced osteoclastogenesis in vitro and in vivo and induces apoptosis mediated by Fas/Fas ligand interactions.

  2011cites this paper
• Skeletal sequelae of cancer and cancer treatment

  2009cites this paper
• Bone metabolism during interferon-alpha treatment of essential thrombocythemia

  2009cites this paper
• Osteoimmunology: cytokines and the skeletal system.

  2008cites this paper
• Osteoimmunology: interactions of the bone and immune system.

  2008cites this paper
• Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon α and ribavirin therapy

  2008cites this paper
• IFN-gamma stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation.

  2007cites this paper
• IFN-γ stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation

  2007cites this paper
• Local immunomodulation with CD4 and CD8 antibodies, but not cyclosporine A, improves osteogenesis induced by ADhBMP9 gene therapy

  2005cites this paper
• Bone mineral density and cytokine levels during interferon therapy in children with chronic hepatitis B: does interferon therapy prevent from osteoporosis?

  2005cites this paper
• Hypocalcemia and Azotemia Associated with Zoledronic Acid and Interferon Alfa

  2004cites this paper
• Ribavirin, but Not Interferon α-2b, is Associated with Impaired Osteoblast Proliferation and Differentiation In Vitro

  2004cites this paper
• Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin‐6 and β2‐microglobulin in multiple myeloma

  2003cites this paper
• Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment

  2001influential citation